Tamás Schneider

Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma

Csaba Bödör, Donát Alpár, Dóra Marosvári et al. · Journal of Neuropathology & Experimental Neurology · 2019 · 44 citations · Full text

Medicine, Molecular Biology, Oncology +17

Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein

Ambrus Gángó, Bence Bátai, Martin Varga et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2018 · 35 citations

Medicine, Genetics, Oncology +15

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Gergely Varga, Zsolt Nagy, Judit Demeter et al. · Pathology & Oncology Research · 2019 · 28 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients

Szilvia Lovas, Gergely Varga, Péter Farkas et al. · International Journal of Hematology · 2019 · 28 citations

Medicine, Oncology, Pharmacology +16

Screening and monitoring of the <i>BTK</i>^C481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

Csaba Bödör, Lili Kotmayer, Tamás László et al. · British Journal of Haematology · 2021 · 21 citations · Full text

Medicine, Immunology, Pharmacotherapy +15